Matthew Harrison, a Managing Director in Research, covers the biotech industry, focusing on companies with market capitalizations of $10 billion and up. He has also covered pharmaceutical stocks, and has been highly ranked among biotech analysts on Institutional Investor’s All-American Research Poll.

Matthew received his Bachelor’s in Physics from Yale University and a Master’s in Physics, as well as a Master’s in Financial Management, from Case Western Reserve University.